FDA warns doctors of counterfeit Botox

Published on NewsOK Modified: December 24, 2012 at 7:54 am •  Published: December 24, 2012
Advertisement
;

WASHINGTON (AP) — Federal regulators have warned more than 350 medical practices that Botox they may have received from a Canadian supplier is unapproved and could be counterfeit or unsafe.

The Food and Drug Administration said in a letter sent last month, a letter released publicly last week, that batches of the wrinkle treatment shipped by suppliers owned by pharmacy Canada Drugs have not been approved by the FDA and that the agency cannot assure their effectiveness or their safety.

The FDA said Canada Drugs was previously tied to shipping unapproved and counterfeit cancer drugs.

The agency warned doctors about buying drugs from sources other than licensed U.S. pharmacies. It is the fifth warning the agency has made this year about foreign suppliers providing unapproved drugs.

In February, the agency warned 19 medical practices that they had received a counterfeit version of the cancer drug Avastin. On three more occasions the FDA issued similar warnings about counterfeit Avastin and Altuzan, another brand name for the same drug. The alerts were also primarily targeted at drugs distributed by Canada Drugs.

Continue reading this story on the...


Trending Now


AROUND THE WEB

  1. 1
    High school football: Sperry rallies for win week after lineman dies
  2. 2
    New video shows beheading of British aid worker David Haines by Islamic State group
  3. 3
    OU football: Jordan Phillips breaks out 'Shmoney dance' after sack against Tennessee
  4. 4
    VIDEO: Oklahoma State WR Brandon Sheperd catches 18-yard touchdown from Daxx Garman
  5. 5
    OSU football: J.W. Walsh watches first quarter of OSU-UTSA from the top of Boone Pickens Stadium
+ show more